BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Genetown

  Frost & Sullivan Recognizes Phase Forward for its Extensive End-to-End Clinical Trial Solutions, Global Impact and Customer Commitment

  March 19, 2009

   · 

  1 min read
• Biotech Bay

  Oculus Innovative Sciences, Inc. Sponsoring RID Symposium at SHEA Conference in San Diego

  March 19, 2009

   · 

  1 min read
• National Cheng Kung University Medical College Launches Biomedical and Nanotechnology Integration Project

  March 19, 2009

   · 

  1 min read
• Business

  Transgenomic, Inc. Reports Fourth Quarter and Fiscal Year 2008 Results

  March 19, 2009

   · 

  7 min read
• Biotech Bay

  Oculus Innovative Sciences, Inc. to Exhibit Its Newest Advances in Microcyn(R) Wound Care at DF Con 09 on March 19-21

  March 19, 2009

   · 

  1 min read
• BioMidwest

  ARCA biopharma Release: Two Gencaro(TM) Posters to Be Presented at the American College of Cardiology 58th Annual Scientific Session

  March 19, 2009

   · 

  1 min read
• Lone Star Bio

  Alcon, Inc. Launches Website for PATANASE(R) Nasal Spray

  March 19, 2009

   · 

  1 min read
• Drug Development

  Novartis Pharmaceuticals Corporation’s Gleevec(R) Substantially Reduces Risk of Cancer Returning in Patients with Life-Threatening Gastrointestinal Stromal Tumors, Lancet Reports

  March 19, 2009

   · 

  11 min read
• Drug Development

  Innocoll, Inc. Announces Dosing of Last Patient in Second US Phase 3 Clinical Trial to Investigate GENTAMICIN SURGICAL IMPLANT for Prevention of Surgical Site Infections in Colorectal Surgery Patients

  March 19, 2009

   · 

  3 min read
• Deals

  XTL Biopharmaceuticals Ltd. Announces the Acquisition of the Use Patent on Recombinant Erythropoietin (rHuEPO) for the Treatment of Multiple Myeloma

  March 19, 2009

   · 

  4 min read